|
|
Oral Abstract Session:
37. Clinical Virology and Treatment
Friday, October 21, 2011: 8:45 AM-10:15 AM
Room: 156ABC
Topical Category: V. Virology including clinical and basic studies of viral infections, including hepatitis
Tracks: Adult ID, Pediatric ID, HIV
Moderators:
Marla Keller, MD, Albert Einstein College of Medicine
and
Ajit Limaye, MD, University of Washington
Presentations:
8:45 AM
|
|
Incidence of intrapartum hepatitis E virus infections in two large prospective cohorts of pregnant Bangladeshi women between 2001 and 2010
Alain Labrique, PhD, MHS, MSc, MACE
;
Brittany Kmush, MS
;
Ronald E. Engle, PhD
;
Kerry Schulze, PhD
;
Keith West, DrPH, RD
;
Robert Purcell, PhD
;
Kenrad Nelson, MD
|
9:00 AM
|
|
HHV-6 Reactivation and Associated Sequelae following Hematopoietic Cell Transplantation
Danielle Zerr, MD, MPH
;
Michael Boeckh, MD, FIDSA
;
Colleen Delaney, MD, MSc
;
Paul Martin, MD
;
Hu Xie, MSc
;
Amanda Adler, BA
;
Meei-Li Huang, PhD
;
Larwrence Corey, MD
;
Wendy Leisenring, ScD
|
9:45 AM
|
|
Randomized, Double-Blind, Pilot Study of Nitazoxanide (NTZ) Versus Placebo (PCB) for the Treatment of Symptoms Associated with Viral Respiratory Infection (VRI) in Adults and Adolescents
Nicolas Lopez-Chegne, MD
;
Luis-Martin Julcamoro, MD
;
Jean-Francois Rossignol, MD, FRCPath, PhD, FRSC
;
Maria Carrion, MD
;
Matthew Bardin, PharmD, BCPS
|
10:00 AM
|
|
Safety and Pharmacokinetics of Acyclovir in Women Following Release from a Silicone Elastomer Vaginal Ring
Marla Keller, MD
;
Amanda Malone, PhD
;
John Moss, PhD
;
Colleen Carpenter, BA
;
Anna Lee, BA
;
Erin Diament, FNP
;
Robyn Willis, BS, GCPharmSc
;
Marc Baum, PhD
;
Betsy C. Herold, MD, FIDSA
;
Thomas Smith, MD
|
CME Credits:
ACPE Credits:
ACPE Number:
Disclosures:
M. Keller,
Auritec Pharmaceuticals, Inc: Investigator, Research support
A. Limaye,
Amgen: Consultant, Consulting fee
Genentech: Consultant, Consulting fee
Vical: Consultant, Consulting fee
BioRad Laboratories: Consultant, Consulting fee
Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.
|